Supports five-year, milestone-driven projects to develop and adapt technologies that identify and characterize senescent cell heterogeneity in tissue environments. Projects include a two-year UG3 phase for technology feasibility and a three-year UH3 phase for optimization, validation, and collaborative demonstration within SenNet. Clinical trials are not permitted.
Eligible applicants include a wide range of U.S. government entities, educational institutions, nonprofits, for-profit organizations, tribal governments, and non-U.S. entities. Both federally recognized and other Native American tribal organizations may apply.
